The developing world is experiencing more Western diseases as they consume more Western products such as fast food, leading to a rise in the cardiology, orthopedics, and cancer rates. This means that the developing world is seeing a growing demand for devices... Read More
There are many new changes in the Japanese medical device regulations. Read More
Japan is a rapidly aging society with one of the highest life expectancies in the world. Today, more than 23% of Japanese -- 30 million people -- are over the age of 65. By 2025, this will jump to 33%. Japan has... Read More
亚洲医疗市场在过去的25年经历了指数级的增长。今天，中国和日本已经是全球排名前5位的大的医疗器械市场。要成功地发展其业务，西方的医疗器械公司应该考虑进入或扩大在亚洲的医疗器械市场的份额。 Read More
There is a wealth of opportunities for healthcare companies looking to expand to the Asian markets. This presentation provides an overview of important business and regulatory issues to consider for medical device companies interested in Asia. To view these presentation slides,... Read More
This Japan drug regulatory PowerPoint presentation covers many basic issues for international drug companies looking to gain more knowledge about the Japanese drug market. It includes information on registering ethical, biological, orphan, and generic drugs in Japan. The presentation also provides information... Read More
Finding the right medical executives for your Japan office can be challenging. If you headhunt a Japanese medical executive and the executive turns out to be not as good as you thought, this could lead to problems in your Japan business. For... Read More
在日本，孤儿药的认定需要通过日本健康，劳动和福利部（MHLW）部。大量的医疗需求要求开发医疗产品，特别是没有可用的替代疗法的疾患。孤儿药的定义是指对于病患数低于50,000安全和有效的药物。然而，孤儿药的指定并不意味着它会自动给予药物的销售许可。 Read More
In Japan, pharmaceutical products can be given orphan drug designation by the Ministry of Health, Labor and Welfare (MHLW). A high medical need must exist for the product, and there must be no available alternative treatment. The drug must also be safe... Read More
In late June 2014, the Japanese Cabinet approved Prime Minister Shinzo Abes new economic growth strategy. One of the proposed reforms is to deregulate some of Japans highly protected industries -- including healthcare. A key pillar of Abes economic strategy is expanding... Read More